Literature DB >> 35300469

European Guideline on IgG4-related digestive disease: UEG and SGF evidence-based recommendations.

Wei On1, Matthew T Huggett1.   

Abstract

Immunoglobulin subclass 4 related disease (IgG4-RD) is an increasingly recognised autoimmune disease with the potential of affecting various organs. It has a predilection for certain anatomical hotspots and the pancreatobiliary tract is the the most common area involved. Due to the relative novelty of IgG4-RD, the understanding of the disease process continues to involve. Recent European guidelines on IgG4-RD have been published by a working group collaboration between the United European Gastroenterology and Swedish Society of Gastroenterology. In our commentary, we aim to extract the key practical points with an emphasis on diagnosis and management of IgG4-RD with specific focus on the pancreatobiliary tract. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  autoimmune biliary disease; hepatobiliary disease; pancreatic disorders

Year:  2021        PMID: 35300469      PMCID: PMC8862498          DOI: 10.1136/flgastro-2021-101884

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  10 in total

Review 1.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

2.  Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Shin Hamada; Ichiro Tsuji; Yoshifumi Takeyama; Tooru Shimosegawa; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2019-12-23       Impact factor: 7.527

Review 3.  Practical guide to the management of chronic pancreatitis.

Authors:  Mustafa Jalal; Jennifer A Campbell; Andrew D Hopper
Journal:  Frontline Gastroenterol       Date:  2018-09-07

Review 4.  United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU).

Authors:  J Matthias Löhr; Enrique Dominguez-Munoz; Jonas Rosendahl; Marc Besselink; Julia Mayerle; Markus M Lerch; Stephan Haas; Fatih Akisik; Nikolaos Kartalis; Julio Iglesias-Garcia; Jutta Keller; Marja Boermeester; Jens Werner; Jean-Marc Dumonceau; Paul Fockens; Asbjorn Drewes; Gürlap Ceyhan; Björn Lindkvist; Joost Drenth; Nils Ewald; Philip Hardt; Enrique de Madaria; Heiko Witt; Alexander Schneider; Riccardo Manfredi; Frøkjer J Brøndum; Sasa Rudolf; Thomas Bollen; Marco Bruno
Journal:  United European Gastroenterol J       Date:  2017-01-16       Impact factor: 4.623

5.  Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.

Authors:  Kensuke Kubota; Terumi Kamisawa; Kazuichi Okazaki; Shigeyuki Kawa; Kenji Hirano; Yoshiki Hirooka; Kazushige Uchida; Hideyuki Shiomi; Hirotaka Ohara; Kyoko Shimizu; Norikazu Arakura; Atsushi Kanno; Junichi Sakagami; Takao Itoi; Tetsuhide Ito; Toshiharu Ueki; Takayoshi Nishino; Kazuo Inui; Nobumasa Mizuno; Hitoshi Yoshida; Masanori Sugiyama; Eisuke Iwasaki; Atshishi Irisawa; Toru Shimosegawa; Yoshifumi Takeyama; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2017-01-06       Impact factor: 7.527

Review 6.  Advances in the diagnosis and management of IgG4 related disease.

Authors:  Marco Lanzillotta; Gaia Mancuso; Emanuel Della-Torre
Journal:  BMJ       Date:  2020-06-16

7.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

8.  International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.

Authors:  Tooru Shimosegawa; Suresh T Chari; Luca Frulloni; Terumi Kamisawa; Shigeyuki Kawa; Mari Mino-Kenudson; Myung-Hwan Kim; Günter Klöppel; Markus M Lerch; Matthias Löhr; Kenji Notohara; Kazuichi Okazaki; Alexander Schneider; Lizhi Zhang
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

9.  Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.

Authors:  Hyon K Choi; John H Stone; Zachary S Wallace; Yuqing Zhang; Cory A Perugino; Ray Naden
Journal:  Ann Rheum Dis       Date:  2019-01-05       Impact factor: 19.103

10.  A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer.

Authors:  Suresh T Chari; Naoki Takahashi; Michael J Levy; Thomas C Smyrk; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Mark A Topazian; Santhi S Vege
Journal:  Clin Gastroenterol Hepatol       Date:  2009-05-04       Impact factor: 11.382

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.